Background & aims Malnutrition has been recognized as a major risk factor for adverse
postoperative outcomes. The ESPEN Symposium on perioperative nutrition was held in …

Life expectancy is increasing and so is the prevalence of age-related non-communicable
diseases (NCDs). Consequently, older people and patients present with multi-morbidities …

The loss of skeletal muscle mass and function is defined as sarcopenia, which might
develop in elderly patients with cancers. It has been indicated as a potential negative factor …

Background The loss of muscle mass, known as sarcopenia, is a natural process of aging
that is associated with adverse health outcomes regardless of age. Because cancer is a …

This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …

Excessive muscle loss is commonly observed in cancer patients and its association with
poor prognosis has been well-established. Cancer-associated sarcopenia differs from age …

Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass
and strength, and survival outcomes of esophageal cancer is controversial. This study aimed …

Background Esophagectomy is the gold-standard treatment for locally advanced
esophageal cancer but has high morbimortality rates. Sarcopenia is a common comorbidity …

Abstract Background In Japan, nivolumab administration is the standard treatment for
patients with unresectable advanced or recurrent esophageal squamous cell carcinoma …

Background Obesity and weight gain have been associated with poor disease-specific and
health-related outcomes in breast cancer survivors (BCS). But the benefits of weight loss in …